TORONTO, Feb. 9, 2017 /CNW/ - Merus Labs International Inc. ("Merus" or the "Company") [TSX: MSL, NASDAQ: MSLI] announced today that it will release its earnings for fiscal Q1 2017 before the market opens on Tuesday, February 14, 2017 and hold a conference call at 8:30 am that same day to discuss the results.
The conference call can be accessed by dialing (+1) 416 764 8688 and entering conference ID: 03788914. North American participants may dial (+1) 888 390 0546. A list of International dial-in numbers will be made available prior to the call. A replay of the call will be available for those not able to attend live by dialing (+1) 888 390 0541.
About Merus Labs
Merus Labs is a specialty pharmaceutical company focused on acquiring and optimizing established and growth products. The Company leverages its expertise and commercial platform in Europe, Canada and select other markets to deliver value.
SOURCE Merus Labs Inc.
For further information: Phone: (905) 726-0995, Email: firstname.lastname@example.org, Website: www.meruslabs.com